---
title: "AZINPHARMA LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/cb1b8d6d-4ecc-5304-bf0d-df22b486de44
json: https://whiteintel.dev/api/public/dossier/cb1b8d6d-4ecc-5304-bf0d-df22b486de44
identifier: oo:GB-COH-08533268
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# AZINPHARMA LTD

**Type:** Company  
**Jurisdiction:** GB  
**Identifier:** `oo:GB-COH-08533268`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/cb1b8d6d-4ecc-5304-bf0d-df22b486de44  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/cb1b8d6d-4ecc-5304-bf0d-df22b486de44  

## Ownership & control

### Owners / controllers

- **Dr Ludka Fyles** (beneficial owner) — 50% — https://whiteintel.dev/entity/d914ddb0-394d-5ec3-a8a9-f91f7625513c
- **Mr David Mark Fyles** (beneficial owner) — 50% — https://whiteintel.dev/entity/8d251ef0-f5cb-512c-be12-2306acbf0cdc
- **Dr Ludka Fyles** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/2d2f69d8-7b08-4bc7-bf84-3892e905165a
- **Mr David Mark Fyles** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/0656a1f1-4321-461d-9d80-7600bd29a274
- **Great Vantage A.S.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/f6d16054-e629-40ef-82f4-a8cbd9a4615a

### UBO chain (walk to the ultimate owner)

1. **Dr Ludka Fyles** — beneficial owner 50% → *AZINPHARMA LTD*
1. **Mr David Mark Fyles** — beneficial owner 50% → *AZINPHARMA LTD*
1. **Dr Ludka Fyles** — beneficial owner 37.5% → *AZINPHARMA LTD*
1. **Mr David Mark Fyles** — beneficial owner 87.5% → *AZINPHARMA LTD*
1. **Great Vantage A.S.** — beneficial owner 87.5% → *AZINPHARMA LTD*

## Company profile (live · UK Companies House)

- **Company number:** `08533268`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2013-05-17
- **Registered office:** 83-85 Baker Street, London, W1U 6AG, United Kingdom
- **SIC:** 74909

### Officers

- LISCHKE, Tereza — director · Czech · appointed 2025-11-20
- FYLES, David Mark — director · British · appointed 2021-05-17 · resigned 2025-11-20
- FYLES, Ludka — director · Czech · appointed 2013-05-17 · resigned 2025-04-04

### Beneficial owners (Persons with Significant Control)

- [Great Vantage A.S.](https://whiteintel.dev/entity/f6d16054-e629-40ef-82f4-a8cbd9a4615a) — 75–100% shares · corporate PSC · Czech Republic — since 2025-11-20
- Mr David Mark Fyles — 75–100% shares · individual PSC · United Kingdom — ceased 2025-11-20
- Dr Ludka Fyles — 25–50% shares · individual PSC · United Kingdom — ceased 2025-04-04

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/08533268
- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/08533268

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **AZINPHARMA LTD**. Human view: https://whiteintel.dev/entity/cb1b8d6d-4ecc-5304-bf0d-df22b486de44 · Structured JSON: https://whiteintel.dev/api/public/dossier/cb1b8d6d-4ecc-5304-bf0d-df22b486de44._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._